ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $346,298 | +36.2% | 7,507 | +18.4% | 0.01% | +25.0% |
| Q1 2023 | $254,274 | +8.7% | 6,341 | +25.6% | 0.00% | 0.0% |
| Q4 2022 | $233,828 | -50.4% | 5,047 | -77.8% | 0.00% | -20.0% |
| Q3 2022 | $471,471 | -92.7% | 22,726 | -74.6% | 0.01% | -93.6% |
| Q1 2022 | $6,498,000 | +75.0% | 89,483 | +129.7% | 0.08% | +129.4% |
| Q2 2021 | $3,714,000 | +450.2% | 38,948 | +146.6% | 0.03% | +183.3% |
| Q4 2019 | $675,000 | +3.8% | 15,793 | +68.4% | 0.01% | -52.0% |
| Q1 2019 | $650,000 | – | 9,378 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |